AI Co-Scientists Move to the Front Lines of Cancer Research

Artificial intelligence systems are beginning to function as "co-scientists" in cancer research, generating drug candidates, prioritizing immunotherapy targets, and guiding experimental design. Emerging platforms now extend beyond analysis and hypothesis generation to participate directly in laboratory workflows, signaling a shift toward AI-augmented discovery across the oncology pipeline.